IP Library Granted Patent US 9,655,982
Granted Patent B2
US 9,655,982 · App. 13/522,718 · Granted May 23, 2017

Formation and uses of europium complexes

Inventors: Matthew J. Allen (Detroit, MI); Nipuni Dhanesha H. Gamage (Detroit, MI); Joel Garcia (Detroit, MI); Jeremiah Moore (Detroit, MI)
Assignee: Wayne State University
A61K49/06A61K49/14C09B57/10C09K11/06C09K2211/182H01L51/0089
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,655,982
App. No.
13/522,718
Granted
May 23, 2017
Kind
B2
Abstract

The present invention provides a method of forming an oxidatively-stable aqueous Eu(II) complex by synthesizing ligands that coordinate to large, soft, electron rich metals like Eu(II). The invention also provides an oxidatively stable aqueous Eu(II) complex. The complex can be used for a variety of purposes some of which include, but are not limited to, in paramagnetic chemical exchange saturation transfer, as a medical diagnostic, as a semiconductor, and for use in forming materials.

Claims (20)

1. An oxidatively-stable Eu(II) complex comprising:

an Eu(II) ion; and

a ligand having a formula selected from the group consisting of:

2. The Eu(II) complex of claim 1 wherein the ligand has formula:

3. The Eu(II) complex of claim 1 wherein the ligand has formula:

4. The Eu(II) complex according to claim 1 , further comprising a compound selected from the group consisting of proteins, dendrimers, biomolecules, and polymers, bound to the Eu(II) complex.

5. The Eu(II) complex according to claim 1 for use as a contrast agent in magnetic resonance imaging.

6. The Eu(II) complex according to claim 1 for use as a contrast agent in ultra-high field magnetic resonance imaging.

7. The Eu(II) complex according to claim 6 , wherein said magnetic resonance imaging uses an ultra-high field that is greater than 3 Tesla.

8. The Eu(II) complex according to claim 1 for use in diagnostic medical applications.

9. An oxidatively-stable Eu(II) complex comprising:

an Eu(II) ion; and

a ligand having a formula selected from the group consisting of:

10. The Eu(II) complex of claim 9 wherein the ligand has formula:

11. The Eu(II) complex of claim 9 wherein the ligand has formula:

12. The Eu(II) complex according to claim 9 , further comprising a compound selected from the group consisting of proteins, dendrimers, biomolecules, and polymers, bound to the Eu(II) complex.

13. The Eu(II) complex according to claim 9 for use as a contrast agent in magnetic resonance imaging.

14. The Eu(II) complex according to claim 9 for use as a contrast agent in ultra-high field magnetic resonance imaging.

15. The Eu(II) complex according to claim 14 , wherein said magnetic resonance imaging uses an ultra-high field that is greater than 3 Tesla.

16. The Eu(II) complex according to claim 9 for use in diagnostic medical applications.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 17, 2017
From: WAYNE STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042265/0961 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2016
From: ALLEN, MATTHEW J.; GAMAGE, NIPUNI DHANESHA H.; GARCIA, JOEL; MOORE, JEREMIAH
To: WAYNE STATE UNIVERSITY
Reel/Frame 039585/0624 →
Continuity (3)
Provisional Application 61296452 · Jan 19, 2010
Provisional Application 61408111 · Oct 29, 2010
Related Publication 20130078189A1 · Mar 28, 2013